Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04576962 · ClinicalTrials.gov registry record
County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 122,152
- Enrollment target
NCT04576962: Completed study, sponsored by Indiana University.
NCT04576962 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 122,152 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04576962 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 122,152 participants
- Enrollment target
Study Summary
The overall objective is to document geographic variability in HPV vaccine series completion across the state of Indiana and to identify factors associated with low versus high rates of completion. Objective a: To map HPV vaccine series completion rates across Indiana's 92 counties for children aged 14 years and younger. Hypothesis: The investigators expect wide variability in completion rates from county to county. Further, the investigators expect significantly less variability in county-level administration of vaccines required for middle-school entry (Tdap, MenACWY, and HepA vaccines). Objective b: To identify county-level characteristics associated with HPV vaccine series completion rates across Indiana's 92 counties. Hypothesis: The investigators expect factors reflective of pragmatic obstacles to be associated with lower completion rates: such as lower population density, fewer primary health care providers (HCP) per capita, longer commute to work, lower median household income, and lower rates of insurance coverage of children.
Primary Outcome
For those children aged 14 years and younger who received the first dose of HPV vaccine in 2017 or 2018 we will measure what percentage complete the second dose of vaccine during 18 months of follow-up.
Interventions
- OTHER Immunization Information System Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122,152 participants |
| Start Date | 2021-02-09 |
| Est. Completion | 2022-01-24 |
What the finished NCT04576962 record still lists
NCT04576962 is an observational study that tracks outcomes without assigning an intervention. Its 122,152 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Immunization Information System Review is the first listed.
NCT04576962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04576962 about?
NCT04576962 is a clinical study titled "County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana". The overall objective is to document geographic variability in HPV vaccine series completion across the state of Indiana and to identify factors associated with low versus high rates of completion. Objective a: To map HPV vaccine series completion rates across Indiana's 92 counties for children age...
What is the current status of trial NCT04576962?
This trial is currently completed. The enrollment target is 122,152 participants. The study started on 2021-02-09. Estimated completion is 2022-01-24.
What interventions are being tested in trial NCT04576962?
The interventions under investigation include: Immunization Information System Review (OTHER).
Who is sponsoring clinical trial NCT04576962?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897374 · 120,000 participants
Strategic Targeting for Optimal Prevention of Cancer
- NCT06608758 · 120,000 participants
End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
- NCT06251323 · 119,680 participants · NA
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI